BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15758645)

  • 21. [Bile acids in the process of canalicular bile formation].
    Sinel'nik TB; Sinel'nik OD; Ribal'chenko VK
    Fiziol Zh (1994); 2003; 49(6):80-93. PubMed ID: 14965044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bile formation and cholestasis].
    Jansen PL; Müller M; Kuipers F
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2384-91. PubMed ID: 11145092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile salts and cholestasis.
    Maillette de Buy Wenniger L; Beuers U
    Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestasis and cholestatic syndromes.
    Pratt DS
    Curr Opin Gastroenterol; 2005 May; 21(3):270-4. PubMed ID: 15818146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
    Pauli-Magnus C; Meier PJ; Stieger B
    Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced cholestasis.
    Erlinger S
    J Hepatol; 1997; 26 Suppl 1():1-4. PubMed ID: 9138122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
    Trauner M; Fickert P; Wagner M
    Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.
    Stieger B; Geier A
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholestasis and cholestatic syndromes.
    O'Leary JG; Pratt DS
    Curr Opin Gastroenterol; 2007 May; 23(3):232-6. PubMed ID: 17414837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling.
    Huang YH; Chuang JH; Yang YL; Huang CC; Wu CL; Chen CL
    Lab Invest; 2009 Oct; 89(10):1128-39. PubMed ID: 19652645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of maternal cholestasis on the kinetics of bile acid transport across the canalicular membrane of infant rat livers.
    Serrano MA; Monte MJ; Martinez-Diez MC; Marin JJ
    Int J Exp Pathol; 1997 Dec; 78(6):383-90. PubMed ID: 9516870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
    Gartung C; Matern S
    Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: physiological basis and pathophysiological changes in cholestatic liver dysfunction.
    Azer SA; Stacey NH
    J Gastroenterol Hepatol; 1996 Apr; 11(4):396-407. PubMed ID: 8713709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention.
    Crocenzi FA; Mottino AD; Roma MG
    Curr Med Chem; 2004 Feb; 11(4):501-24. PubMed ID: 14965230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.